1. Home
  2. Live Updates
  3. Adalimumab

Page 6 - Adalimumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adalimumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adalimumab Today - Breaking & Trending Today

Defining Interchangeability and Switching in Biologics

Medical experts discuss interchangeability designation requirements for biosimilars. ....

Ryan Haumschild , Bincy Abraham , Aliceb Gottlieb , Vibeke Strand , Reference Product , Cpt 13 ,

Switching Patients from Reference Product to Biosimilar

Insight surrounding the switch from reference drugs to biosimilars is provided by Bincy Abraham, MD, MS. ....

Bincy Abraham , Ryan Haumschild , Aliceb Gottlieb , Vibeke Strand , Reference Drug ,

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1

In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more. ....

Ryan Haumschild , Pharmacy Services At Emory Healthcare , Winship Cancer Institute , Pharmacy Services , Emory Healthcare , Winship Cancer ,

FDA Accepts sBLA for Interchangeability Designation for Adalimumab-bwwd

HADLIMA is currently indicated for psoriatic arthritis, plaque psoriasis, and hidradenitis suppurativa, among others. ....

United States , Jon Martin , Samsung Bioepis Co Ltd , Organon Co , Regulatory Affairs Team Leader At Samsung Bioepis , Supplemental Biologics License Application , Araki Illustrations , Byoung In Jung , Vice President , Regulatory Affairs Team Leader , Samsung Bioepis ,

Nationwide Switch to Adalimumab Biosimilar Led to Greater Workload, Decreased Satisfaction

This is the first research to allow for greater insight into the impacts on providers of a nationwide change to an adalimumab biosimilar. ....

New Zealand , Chiara Gasteiger , Adalimumab Biosimilar , University Of Auckland , Zealand Rheumatology Association , Management Agency , Society Of New Zealand , Zealand Rheumatology Health Professionals Association , Dalbethn Health Care Provider , Aotearoa New Zealand , New Zealand Rheumatology Association , Pharmaceutical Society , Care Provider Experiences , Mandatory Nationwide Transition ,